Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity
Authors
Keywords
-
Journal
Nanomedicine
Volume 16, Issue 17, Pages 1457-1469
Publisher
Future Medicine Ltd
Online
2021-06-16
DOI
10.2217/nnm-2021-0103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone
- (2020) Ali H. El-Far et al. INTEGRATIVE CANCER THERAPIES
- Cockle Shell-Derived Aragonite CaCO3 Nanoparticles for Co-Delivery of Doxorubicin and Thymoquinone Eliminates Cancer Stem Cells
- (2020) Kehinde Muibat Ibiyeye et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation
- (2020) Deena S Mousa et al. International Journal of Nanomedicine
- Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models
- (2020) Thangirala Sudha et al. MOLECULES
- The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model
- (2020) Mohammed S. Almuhayawi et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising its Anticancer Efficacy in Breast Cancer
- (2020) Kavitha Godugu et al. MOLECULES
- Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats
- (2020) Derya Karabulut et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle
- (2019) Weikun Li et al. Scientific Reports
- Ultrastructural Changes and Antitumor Effects of Doxorubicin/Thymoquinone-Loaded CaCO3 Nanoparticles on Breast Cancer Cell Line
- (2019) Kehinde Muibat Ibiyeye et al. Frontiers in Oncology
- Bioactive Compounds: Natural Defense Against Cancer?
- (2019) Shonia Subramaniam et al. Biomolecules
- Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer
- (2018) Nashwa Kabil et al. BREAST CANCER RESEARCH AND TREATMENT
- Thymoquinone Ameliorates Doxorubicin-Induced Cardiotoxicity in Swiss Albino Mice by Modulating Oxidative Damage and Cellular Inflammation
- (2018) Mohammad Firoz Alam et al. Cardiology Research and Practice
- Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases
- (2018) Ali El-Far et al. Nutrients
- Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
- (2018) Mustafa S. Atta et al. Oxidative Medicine and Cellular Longevity
- Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly- N -acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma
- (2017) Nahla E. El-Ashmawy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
- (2017) Thangirala Sudha et al. International Journal of Nanomedicine
- Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1
- (2017) Jun Li et al. MOLECULES
- Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation
- (2017) Hsi-Hsien Hsu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
- (2017) Navid Koleini et al. Oncotarget
- MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion
- (2017) Saber Imani et al. Oncotarget
- Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB
- (2016) Lida Zhang et al. Oncology Letters
- Thymoquinone Induces Caspase-Independent, Autophagic Cell Death in CPT-11-Resistant LoVo Colon Cancer via Mitochondrial Dysfunction and Activation of JNK and p38
- (2015) Ming-Cheng Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- An overview of doxorubicin formulations in cancer therapy
- (2015) Sangeeta Rivankar Journal of Cancer Research and Therapeutics
- Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src-mediated phosphorylation of EGF receptor tyrosine kinase
- (2014) JUTHIKA KUNDU et al. ONCOLOGY REPORTS
- Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin
- (2010) Katharina Effenberger-Neidnicht et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells
- (2010) El-Shaimaa A. Arafa et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling
- (2009) Nahed El-Najjar et al. APOPTOSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now